Risk factors for posterior capsule opacification following phacovitrectomy: a six-year retrospective analysis
Mieszko Lachota1, Agata Frajdenberg2, Karolina Radl Steiner2
1Department of Ophthalmology, Children's Memorial Health Institute, Warsaw, Poland. m.lachota@ipczd.pl.
International Ophthalmology
|March 11, 2026
Summary
Intraocular lens (IOL) type significantly impacts the need for Nd:YAG capsulotomy (YAG-CT) after phacovitrectomy (PhV). Choosing specific hydrophilic acrylic IOLs can reduce YAG-CT incidence, especially in patients with retinal disease or diabetes.
Area of Science:
- Ophthalmology
- Surgical Outcomes
- Biomaterials Science
Background:
- Posterior capsule opacification (PCO) can cause visual disturbances after cataract surgery.
- Nd:YAG capsulotomy (YAG-CT) is a common procedure to address visually significant PCO.
- Phacovitrectomy (PhV) combines cataract extraction and vitrectomy, and PCO risk factors require investigation.
Purpose of the Study:
- To identify risk factors for YAG-CT following PhV.
- To evaluate the influence of intraocular lens (IOL) type on YAG-CT incidence.
- To assess the impact of underlying retinal conditions and systemic diseases on PCO development post-PhV.
Main Methods:
- Retrospective comparative cohort study of 196 patients (197 eyes) undergoing PhV.
- Analysis of electronic medical records for patient data, surgical details, and IOL type.
- Regression analyses to determine associations between various factors and YAG-CT incidence over a 6-year follow-up.
Main Results:
- 27.41% of eyes required YAG-CT.
- Hydrophobic acrylic IOLs and two types of hydrophilic acrylic IOLs showed significantly higher YAG-CT incidence compared to one specific hydrophilic acrylic IOL.
- PhV for epiretinal membranes, retinal detachment, silicon oil removal, and type 2 diabetes were associated with increased YAG-CT risk.
Conclusions:
- IOL type is a critical determinant of visually disturbing PCO after PhV.
- A specific hydrophilic acrylic IOL demonstrated superior performance in minimizing YAG-CT incidence.
- Consideration of IOL choice is crucial for patients undergoing PhV, particularly those with retinal diseases or type 2 diabetes, to mitigate PCO development.
Related Concept Videos
Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.5K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K


